AstraZeneca PLC (NASDAQ:AZN) is one of the 10 best defensive stocks to buy in a volatile market. On July 4, the company entered into a multi-year agreement with Modella AI.

AstraZeneca (NASDAQ: AZN) might soon be on the hook for an eventual 11-figure payout, and investors weren't all that comfortable with this. A Bloomberg article published Thursday morning said that ...

Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. CEO Pascal Soriot is ...

Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market listing and even the ...

AstraZeneca has started the process to improve its cancer treatment capabilities with an addition to its campus in southwest Frederick.

AstraZeneca paid Japan’s Daiichi Sankyo a whopping $1 billion upfront back in 2020, and tacked on a potential $5 billion in milestone payments, for the chance to co-develop the antibody-drug conjugate ...